AWM
RIGL icon

Avior Wealth Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Avior Wealth Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-356
Closed -$5.99K – 1973
2024
Q4 		$5.99K Buy
+356
New +$6.83K ﹤0.01% 1798
2024
Q3 		– Sell
-126
Closed -$1.03K – 2396
2024
Q2 		$1.03K Sell
126
-5
-4% -$52 ﹤0.01% 2023
2024
Q1 		$1.93K Buy
131
+4
+3% +$54 ﹤0.01% 2278
2023
Q4 		$1.84K Buy
+127
New +$1.3K ﹤0.01% 1310

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CLGM
Capitolis Liquid Global Markets New York $15.7B AUM 30.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Avior Wealth Management's RIGL Position: Q1 2025 in Review

Avior Wealth Management sold out of Rigel Pharmaceuticals (RIGL) in Q1 2025, closing a stake of 356 shares — an estimated $5.99K sold.

Avior Wealth Management first reported a position in RIGL in Q4 2023 and held it in 4 quarters. The position peaked at $5.99K in Q4 2024. 123 funds tracked by Wall St. Rank hold RIGL as of Q1 2025.

  • Avior Wealth Management reported no remaining Rigel Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Avior Wealth Management sold 356 Rigel Pharmaceuticals shares in Q1 2025, an estimated $5.99K.
  • Avior Wealth Management first reported a position in Rigel Pharmaceuticals in Q4 2023 and held it in 4 quarters.
  • Avior Wealth Management's Rigel Pharmaceuticals position peaked at $5.99K in Q4 2024.
  • 123 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2025.

Based on Avior Wealth Management's 13F filing for Q1 2025, filed 21 Apr 2025.